These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29195064)

  • 1. The Ferrous Awakens.
    Rennekamp AJ
    Cell; 2017 Nov; 171(6):1225-1227. PubMed ID: 29195064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ferroptosis, a new form of cell death relevant to the medical treatment of cancer].
    Lachaier E; Louandre C; Ezzoukhry Z; Godin C; Mazière JC; Chauffert B; Galmiche A
    Med Sci (Paris); 2014; 30(8-9):779-83. PubMed ID: 25174755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases.
    Yu H; Guo P; Xie X; Wang Y; Chen G
    J Cell Mol Med; 2017 Apr; 21(4):648-657. PubMed ID: 27860262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bio-active Natural Products with TRAIL-Resistance Overcoming Activity.
    Ahmed F; Ishibashi M
    Chem Pharm Bull (Tokyo); 2016; 64(2):119-27. PubMed ID: 26833440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of baicalein as a ferroptosis inhibitor by natural product library screening.
    Xie Y; Song X; Sun X; Huang J; Zhong M; Lotze MT; Zeh HJ; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 May; 473(4):775-780. PubMed ID: 27037021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to resistance to anticancer agents.
    Kruh GD
    Oncogene; 2003 Oct; 22(47):7262-4. PubMed ID: 14576836
    [No Abstract]   [Full Text] [Related]  

  • 7. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
    Lachaier E; Louandre C; Godin C; Saidak Z; Baert M; Diouf M; Chauffert B; Galmiche A
    Anticancer Res; 2014 Nov; 34(11):6417-22. PubMed ID: 25368241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New targets for cancer chemotherapy.
    Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
    Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in studies on inhibitor of apoptosis proteins and cancer therapy].
    Wang XH; Fu LW
    Yao Xue Xue Bao; 2006 Feb; 41(2):103-7. PubMed ID: 16671537
    [No Abstract]   [Full Text] [Related]  

  • 10. Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.
    Wang YJ; Li Q; Xiao HB; Li YJ; Yang Q; Kan XX; Chen Y; Liu XN; Weng XG; Chen X; Cai WY; Guo Y; Huang HF; Zhu XX
    Drug Des Devel Ther; 2015; 9():5301-13. PubMed ID: 26445529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells.
    Zhao J; Lu Y; Shen HM
    Cancer Lett; 2012 Jan; 314(1):8-23. PubMed ID: 22030255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming resistance to apoptosis in cancer therapy.
    Hersey P; Zhang XD; Mhaidat N
    Adv Exp Med Biol; 2008; 615():105-26. PubMed ID: 18437893
    [No Abstract]   [Full Text] [Related]  

  • 13. Combating apoptosis and multidrug resistant cancers by targeting lysosomes.
    Groth-Pedersen L; Jäättelä M
    Cancer Lett; 2013 May; 332(2):265-74. PubMed ID: 20598437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL).
    Fulda S
    Adv Exp Med Biol; 2014; 818():167-80. PubMed ID: 25001536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A change of strategy in the war on cancer.
    Gatenby RA
    Nature; 2009 May; 459(7246):508-9. PubMed ID: 19478766
    [No Abstract]   [Full Text] [Related]  

  • 16. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
    Hu X; Xuan Y
    Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting apoptosis pathways in childhood malignancies.
    Fulda S
    Cancer Lett; 2013 May; 332(2):369-73. PubMed ID: 21036468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correction of DNA methylation disorder as a possible way to modulation of malignant cells drug resistance].
    Chekhun VF; Mykytenko DO; Luk'ianova NIu; Pohribnyĭ IP
    Ukr Biokhim Zh (1999); 2006; 78(6):5-14. PubMed ID: 17494313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming drug resistance in multiple myeloma: the emergence of therapeutic approaches to induce apoptosis.
    Yang HH; Ma MH; Vescio RA; Berenson JR
    J Clin Oncol; 2003 Nov; 21(22):4239-47. PubMed ID: 14615454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.